Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative Staphylococcus in a neonatal intensive care unit

Pediatrics

Volumn 117, Issue 2, 2006, Pages 340-348

  Khashu, Minesh ^a   Osiovich, Horacio ^a,b   Henry, Deborah ^a   Al Khotani, Aziz ^a   Solimano, Alfonso ^a   Speert, David P ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

DNA fingerprinting; Neonatal sepsis; Staphylococcus epidermidis

Indexed keywords

CEFOTAXIME; OXACILLIN; PENICILLIN G; RIFAMPICIN; VANCOMYCIN; COAGULASE;

ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CENTRAL VENOUS CATHETERIZATION; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG BLOOD LEVEL; HUMAN; INFECTION RISK; MICROBIOLOGICAL EXAMINATION; MOLECULAR TYPING; MORBIDITY; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; SEPSIS; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOCYTOPENIA; CROSS INFECTION; ENZYMOLOGY; METABOLISM; MICROBIOLOGY; RISK FACTOR; STAPHYLOCOCCUS; STAPHYLOCOCCUS INFECTION; THROMBOCYTE TRANSFUSION; VERY LOW BIRTH WEIGHT;

BACTEREMIA; COAGULASE; CROSS INFECTION; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; PLATELET TRANSFUSION; RISK FACTORS; SEPSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; THROMBOCYTOPENIA;

EID: 33644849920     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-0333     Document Type: Article

References (31)

1. Isaacs D, Barfield C, Clothier T, et al. Late-onset infections of infants in neonatal units. J Paediatr Child Health. 1996;32:158-161
2. Isaacs D. A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units. Arch Dis Child Fetal Neonatal Ed. 2003;88:F89-F93
3. Mehr SS, Sadowsky JL, Doyle LW, Carr J. Sepsis in neonatal intensive care in the late 1990s. J Paediatr Child Health. 2002;38:246-251
4. Ronnestad A, Abrahamsen TG, Gaustad P, Finne PH. Blood culture isolates during 6 years in a tertiary neonatal intensive care unit. Scand J Infect Dis. 1998;30:245-251
5. Karlowicz MG, Buescher ES, Surka AE. Fulminant late-onset sepsis in a neonatal intensive care unit, 1988-1997, and the impact of avoiding empiric vancomycin therapy. Pediatrics. 2000;106:1387-1390
6. Lawrence S, Roth V, Slinger R, Toye B, Tierney M. Cloxacillin versus vancomycin for presumed late-onset sepsis in the NICU: impact on CONS sepsis outcomes. Pediatr Child Health 2002;7:27A
7. Matrai-Kovalskis Y, Greenberg D, Shinwell ES, Fraser D, Dagan R. Positive blood cultures for coagulase-negative staphylococci in neonates: does highly selective vancomycin usage affect outcome? Infection. 1998;26:85-92
8. Rubin LG, Sanchez PJ, Siegel J, Levine G, Saiman L, Jarvis WR. Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics. 2002;110(4). Available at: www.pediatrics.org/cgi/content/full/110/4/e42
9. Struelens MJ, Deplano A, Godard C, Maes N, Serruys E. Epidemiologic typing and delineation of genetic relatedness of methicillin-resistant Staphylococcus aureus by macrorestriction analysis of genomic DNA by using pulsed-field gel electrophoresis. J Clin Microbiol. 1992;30:2599-2605
10. Bingen E, Barc M-C, Brahimi N, Vilmer E, Beaufils F. Randomly amplified polymorphic DNA analysis provides rapid differentiation of methicillin-resistant coagulase negative Staphylococcus bacteremia isolates in pediatric hospital. J Clin Microbiol. 1995;33:1657-1659
11. Mahenthiralingam E, Campbell ME, Foster J, Lam JS, Speert DP. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J Clin Microbiol. 1996;34:1129-1135
12. Stoll BJ, Gordon T, Korones SB, et al. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J Pediatr. 1996;129:63-71
13. Gaynes RP, Edwards JR, Jarvis WR, Culver DH, Tolson JS, Martone WJ. Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics. 1996;98:357-361
14. St Geme JW III, Harris MC. Coagulase-negative staphylococcal infection in the neonate. Clin Perinatol. 1991;18:281-302
15. Chapman RL, Faix RG. Persistent bacteremia and outcome in late onset infection among infants in a neonatal intensive care unit. Pediatr Infect Dis J. 2003;22:17-21
16. Patrick CC, Kaplan SL, Baker CJ, Parisi JT, Mason EO Jr. Persistent bacteremia due to coagulase-negative staphylococci in low birth weight neonates. Pediatrics. 1989;84:977-985
17. Auriti C, Maccallini A, Di Liso G, Di Ciommo V, Ronchetti MP, Orzalesi M. Risk factors for nosocomial infections in a neonatal intensive-care unit. J Hosp Infect. 2003;53:25-30
18. Fanaroff AA, Korones SB, Wright LL, et al. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J. 1998;17:593-598
19. Healy CM, Palazzi DL, Edwards MS, Campbell JR, Baker CJ. Features of invasive staphylococcal disease in neonates. Pediatrics. 2004;4:953-961
20. Karlowicz MG, Furigay PJ, Croitoru DP, Buescher ES. Central venous catheter removal versus in situ treatment in neonates with coagulase-negative staphylococcal bacteremia. Pediatr Infect Dis J. 2002;21:22-27
21. Benjamin DK Jr, Miller W, Garges H, et al. Bacteremia, central catheters, and neonates: when to pull the line. Pediatrics. 2001;107:1272-1276
22. Sung L, Ramotar K, Samson LM, Toye B. Bacteremia due to persistent strains of coagulase-negative staphylococci in a neonatal intensive-care unit. Infect Control Hosp Epidemiol. 1999;20:349-351
23. Freeman J, Goldmann DA, Smith NE, Sidebottom DG, Epstein MF, Platt R. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med. 1990;323:301-308
24. Okada Y, Klein NJ, van Saene HK, Webb G, Holzel H, Pierro A. Bactericidal activity against coagulase-negative staphylococci is impaired in infants receiving long-term parenteral nutrition. Ann Surg. 2000;231:276-281
25. Shiro H, Muller E, Takeda S, Tosteson TD, Goldmann DA, Pier GB. Potentiation of Staphylococcus epidermidis catheter-related bacteremia by lipid infusions. J Infect Dis. 1995;171:220-224
26. Shama A, Patole SK, Whitehall JS. Intravenous rifampicin in neonates with persistent staphylococcal bacteraemia. Acta Paediatr. 2002;91:670-673
27. Villari P, Sarnataro C, Iacuzio L. Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period. J Clin Microbiol. 2000;38:1740-1746
28. Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis: emerging resistance and need for alternative agents. Clin Infect Dis. 1998;26:1182-1187
29. Howe RA, Monk A, Wootton M, Walsh TR, Enright MC. Vancomycin susceptibility within methicillin-resistant Staphylococcus aureus lineages. Emerg Infect Dis. 2004;10:855-857
30. Tan TQ, Mason EO Jr, Ou CN, Kaplan SL. Use of intravenous rifampin in neonates with persistent staphylococcal bacteremia. Antimicrob Agents Chemother. 1993;37:2401-2406
31. Swanberg L, Tuazon CU. Rifampin in the treatment of serious staphylococcal infections. Am J Med Sci. 1984;287:49-54